Vector Control Advisory Group
Independent evaluation of the public health value of innovative new tools, technologies and approaches for vector control is needed to enable WHO to provide evidence-based advice to Member States on whether their deployment is justified. This is essential to ensure that scarce resources available for disease control are used to maximum impact. In order to assist WHO in developing public health policy on new tools, the Vector Control Advisory Group (VCAG) assesses the public health value of new interventions and provides guidance on developing the evidence base required to inform such assessments.
Learn more

New tools, technologies and approaches for vector control

This section provides an overview of new tools, technologies and approaches for vector control – collectively referred to as “interventions” – that have been submitted to WHO for evaluation. It is targeted at non-experts as an introduction to this rapidly evolving field. If the interventions under evaluation by WHO demonstrate efficacy in controlling diseases such as malaria, dengue, Zika virus disease, chikungunya and leishmaniasis, WHO will formulate new policy recommendations or amend existing ones to support their deployment.

The WHO evaluation process for new vector control interventions is intended to guide innovators on the data requirements for and design of epidemiological trials and then to review the results of trials to determine whether the intervention reduces or prevents infection and/or disease in humans. Innovators are supported in this process by the WHO Vector Control Advisory Group (VCAG). The evaluation of epidemiological impact is complemented by an assessment of the intervention’s safety, quality and efficacy, which is conducted by the WHO Prequalification Team for vector control (PQT-VC).

Interventions under evaluation by WHO

Interventions under evaluation include the following types and classes:

Last update: 18 June 2020